Echelon Biosciences - A phosphatidylinositol kinase could be a new target for autoimmune therapy

A phosphatidylinositol kinase could be a new target for autoimmune therapy

Interleukin-17 (IL-17) is a cytokine produced by a specific type of T cell and is involved in restricting invasive microbes. […]

A phosphatidylinositol kinase could be a new target for autoimmune therapy Read More »